.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

SOLAGE Drug Profile

« Back to Dashboard
Solage is a drug marketed by Aqua Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has thirteen patent family members in twelve countries.

The generic ingredient in SOLAGE is mequinol; tretinoin. Additional details are available on the mequinol; tretinoin profile page.

Summary for Tradename: SOLAGE

Patents:1
Applicants:1
NDAs:1
Formulation / Manufacturing:see details

Clinical Trials for: SOLAGE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 1999DISCNNo6,353,029<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SOLAGE

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 19995,194,247<disabled>
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 19995,470,567<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: SOLAGE

Country Document Number Estimated Expiration
Japan2004506666<disabled in preview>
Brazil0113460<disabled in preview>
Canada2419877<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc